6 04, 2021 Europe approves the first anti PD-1/L1 therapy for patients with MSI-H/dMMR colorectal cancer Diatech Pharmacogenetics 2021-04-07T10:43:50+00:00 Mehr erfahren
6 04, 2021 Approvata in Europa la prima terapia anti-PD-1/L1 per i pazienti con tumore del colon-retto MSI-H/dMMR Diatech Pharmacogenetics 2021-04-06T10:47:34+00:00 Mehr erfahren
25 02, 2021 A breakthrough for the targeted therapy of RET+ tumours with new selective inhibitors Diatech Pharmacogenetics 2021-04-06T10:59:55+00:00 Mehr erfahren
